Annovis Historical Balance Sheet

ANVS Stock

USD 6.71 0.17 2.60%

Trend analysis of Annovis Bio balance sheet accounts such as Other Current Liab of 3.1 M, Total Current Liabilities of 3 M or Net Tangible Assets of 53.7 M provides information on Annovis Bio's total assets, liabilities, and equity, which is the actual value of Annovis Bio to its prevalent stockholders. By breaking down trends over time using Annovis Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Annovis Bio Inventory

(637.53 Million)

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.

About Annovis Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Annovis Bio at a specified time, usually calculated after every quarter, six months, or one year. Annovis Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Annovis Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Annovis currently owns. An asset can also be divided into two categories, current and non-current.

Annovis Bio Balance Sheet Chart

At this time, Annovis Bio's Intangible Assets are comparatively stable compared to the past year. Other Assets is likely to gain to about 662.6 K in 2024, despite the fact that Total Stockholder Equity is likely to grow to (7.4 M).

Total Assets Other Current Liab Total Current Liabilities Accounts Payable Property Plant Equipment

Total Assets

Total assets refers to the total amount of Annovis Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Annovis Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Annovis Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Annovis Bio are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Annovis Bio obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Annovis Bio are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from Annovis Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Annovis Bio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.At this time, Annovis Bio's Intangible Assets are comparatively stable compared to the past year. Other Assets is likely to gain to about 662.6 K in 2024, despite the fact that Total Stockholder Equity is likely to grow to (7.4 M).

	2021	2022	2023	2024 (projected)
Other Current Liabilities	818.4K	3.7M	3.0M	3.1M
Total Assets	46.0M	36.0M	10.2M	14.9M

Other Current Liab Total Assets

Annovis Bio balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Net Receivables	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Other Assets	Good Will	Net Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Net Invested Capital
Total Assets		0.47	0.62	0.92	0.75	-0.36	0.52	0.93	0.21	-0.03	-0.16	0.65	-0.04	0.99	0.12	-0.15	0.23	0.19	-0.15	-0.92	0.92	0.67	0.62	-0.34	0.7	0.89
Other Current Liab	0.47		0.63	0.16	0.83	-0.89	0.29	0.42	-0.2	-0.27	-0.04	0.89	0.67	0.5	-0.42	-0.23	-0.2	-0.15	-0.3	-0.39	0.38	0.78	0.81	0.44	0.86	0.28
Total Current Liabilities	0.62	0.63		0.42	0.59	-0.47	0.91	0.35	0.54	0.13	0.01	0.52	0.39	0.55	0.36	-0.2	0.57	0.49	-0.26	-0.32	0.32	0.45	0.53	0.14	0.51	0.29
Total Stockholder Equity	0.92	0.16	0.42		0.5	-0.03	0.41	0.89	0.21	0.1	-0.19	0.36	-0.42	0.91	0.24	0.0	0.21	0.15	0.02	-0.9	0.9	0.44	0.39	-0.64	0.43	0.93
Net Tangible Assets	0.75	0.83	0.59	0.5		-0.88	0.34	0.69	-0.05	-0.09	-0.21	0.98	0.45	0.76	-0.24	-0.12	-0.03	0.05	-0.21	-0.66	0.65	0.94	0.86	0.23	0.98	0.54
Retained Earnings	-0.36	-0.89	-0.47	-0.03	-0.88		-0.18	-0.31	0.15	0.17	0.12	-0.93	-0.75	-0.37	0.43	0.2	0.15	0.06	0.32	0.27	-0.26	-0.84	-0.8	-0.61	-0.89	-0.12
Accounts Payable	0.52	0.29	0.91	0.41	0.34	-0.18		0.19	0.82	0.36	0.02	0.22	0.19	0.41	0.69	-0.13	0.85	0.76	-0.16	-0.17	0.16	0.18	0.22	0.03	0.21	0.16
Cash	0.93	0.42	0.35	0.89	0.69	-0.31	0.19		-0.11	-0.24	-0.14	0.63	-0.12	0.97	-0.15	-0.15	-0.1	-0.14	-0.13	-1.0	1.0	0.68	0.63	-0.45	0.7	0.97
Net Receivables	0.21	-0.2	0.54	0.21	-0.05	0.15	0.82	-0.11		0.52	-0.07	-0.18	-0.03	0.09	0.81	-0.2	0.98	0.82	-0.22	0.12	-0.12	-0.2	-0.21	-0.02	-0.19	-0.11
Inventory	-0.03	-0.27	0.13	0.1	-0.09	0.17	0.36	-0.24	0.52		-0.15	-0.24	-0.36	-0.13	0.69	0.57	0.49	0.67	0.53	0.24	-0.25	-0.28	-0.33	0.08	-0.25	-0.24
Other Current Assets	-0.16	-0.04	0.01	-0.19	-0.21	0.12	0.02	-0.14	-0.07	-0.15		-0.17	0.13	-0.16	-0.07	-0.08	-0.06	-0.11	-0.06	0.15	-0.14	-0.18	0.2	0.07	-0.17	-0.14
Other Stockholder Equity	0.65	0.89	0.52	0.36	0.98	-0.93	0.22	0.63	-0.18	-0.24	-0.17		0.56	0.67	-0.39	-0.18	-0.17	-0.09	-0.27	-0.6	0.59	0.95	0.89	0.32	1.0	0.47
Total Liab	-0.04	0.67	0.39	-0.42	0.45	-0.75	0.19	-0.12	-0.03	-0.36	0.13	0.56		-0.04	-0.32	-0.37	0.01	0.02	-0.45	0.17	-0.17	0.39	0.46	0.83	0.5	-0.32
Total Current Assets	0.99	0.5	0.55	0.91	0.76	-0.37	0.41	0.97	0.09	-0.13	-0.16	0.67	-0.04		0.0	-0.17	0.1	0.05	-0.17	-0.96	0.96	0.7	0.66	-0.37	0.73	0.93
Intangible Assets	0.12	-0.42	0.36	0.24	-0.24	0.43	0.69	-0.15	0.81	0.69	-0.07	-0.39	-0.32	0.0		0.35	0.87	0.9	0.36	0.16	-0.15	-0.39	-0.41	-0.19	-0.39	-0.1
Common Stock	-0.15	-0.23	-0.2	0.0	-0.12	0.2	-0.13	-0.15	-0.2	0.57	-0.08	-0.18	-0.37	-0.17	0.35		-0.11	0.27	0.98	0.14	-0.14	-0.2	-0.22	0.0	-0.18	-0.12
Property Plant Equipment	0.23	-0.2	0.57	0.21	-0.03	0.15	0.85	-0.1	0.98	0.49	-0.06	-0.17	0.01	0.1	0.87	-0.11		0.88	-0.13	0.12	-0.12	-0.18	-0.2	-0.01	-0.17	-0.1
Other Assets	0.19	-0.15	0.49	0.15	0.05	0.06	0.76	-0.14	0.82	0.67	-0.11	-0.09	0.02	0.05	0.9	0.27	0.88		0.26	0.16	-0.17	-0.13	-0.21	0.14	-0.1	-0.18
Good Will	-0.15	-0.3	-0.26	0.02	-0.21	0.32	-0.16	-0.13	-0.22	0.53	-0.06	-0.27	-0.45	-0.17	0.36	0.98	-0.13	0.26		0.12	-0.12	-0.27	-0.31	-0.1	-0.26	-0.09
Net Debt	-0.92	-0.39	-0.32	-0.9	-0.66	0.27	-0.17	-1.0	0.12	0.24	0.15	-0.6	0.17	-0.96	0.16	0.14	0.12	0.16	0.12		-1.0	-0.65	-0.61	0.48	-0.67	-0.98
Cash And Short Term Investments	0.92	0.38	0.32	0.9	0.65	-0.26	0.16	1.0	-0.12	-0.25	-0.14	0.59	-0.17	0.96	-0.15	-0.14	-0.12	-0.17	-0.12	-1.0		0.64	0.61	-0.49	0.66	0.98
Common Stock Total Equity	0.67	0.78	0.45	0.44	0.94	-0.84	0.18	0.68	-0.2	-0.28	-0.18	0.95	0.39	0.7	-0.39	-0.2	-0.18	-0.13	-0.27	-0.65	0.64		0.89	0.1	0.96	0.56
Common Stock Shares Outstanding	0.62	0.81	0.53	0.39	0.86	-0.8	0.22	0.63	-0.21	-0.33	0.2	0.89	0.46	0.66	-0.41	-0.22	-0.2	-0.21	-0.31	-0.61	0.61	0.89		0.15	0.9	0.52
Non Current Liabilities Total	-0.34	0.44	0.14	-0.64	0.23	-0.61	0.03	-0.45	-0.02	0.08	0.07	0.32	0.83	-0.37	-0.19	0.0	-0.01	0.14	-0.1	0.48	-0.49	0.1	0.15		0.24	-0.64
Capital Surpluse	0.7	0.86	0.51	0.43	0.98	-0.89	0.21	0.7	-0.19	-0.25	-0.17	1.0	0.5	0.73	-0.39	-0.18	-0.17	-0.1	-0.26	-0.67	0.66	0.96	0.9	0.24		0.54
Net Invested Capital	0.89	0.28	0.29	0.93	0.54	-0.12	0.16	0.97	-0.11	-0.24	-0.14	0.47	-0.32	0.93	-0.1	-0.12	-0.1	-0.18	-0.09	-0.98	0.98	0.56	0.52	-0.64	0.54

Click cells to compare fundamentals

Annovis Bio Account Relationship Matchups

Annovis Bio balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.1M	8.1M	46.0M	36.0M	10.2M	14.9M
Other Current Liab	776.9K	236.5K	818.4K	3.7M	3.0M	3.1M
Total Current Liabilities	2.0M	578.4K	1.5M	7.7M	4.3M	3.0M
Total Stockholder Equity	(8.6M)	7.5M	44.5M	28.3M	(7.8M)	(7.4M)
Net Tangible Assets	(7.6M)	(8.6M)	7.5M	44.5M	51.2M	53.7M
Retained Earnings	(8.8M)	(14.2M)	(28.7M)	(54.1M)	(110.3M)	(104.7M)
Accounts Payable	1.2M	341.9K	688.1K	4.0M	1.3M	1.5M
Cash	1.9K	8.1M	45.7M	28.4M	5.8M	9.4M
Other Current Assets	745.7M	38.2K	72.8K	104.9K	4.5M	4.2M
Other Stockholder Equity	200.6K	21.8M	73.2M	82.4M	102.5M	107.6M
Total Liab	9.7M	578.4K	1.5M	7.7M	18.0M	18.9M
Total Current Assets	747.5K	8.1M	46.0M	36.0M	10.2M	12.9M
Net Debt	497.9K	(8.1M)	(45.7M)	(28.4M)	(5.8M)	(6.0M)
Cash And Short Term Investments	1.9K	8.1M	45.7M	28.4M	5.8M	5.5M
Common Stock Shares Outstanding	6.8M	6.3M	7.6M	8.2M	9.0M	7.3M
Liabilities And Stockholders Equity	1.1M	8.1M	46.0M	36.0M	10.2M	16.0M
Non Current Liabilities Total	7.7M	341.9K	688.1K	4.0M	13.7M	14.4M
Capital Surpluse	192.1K	200.6K	21.8M	73.2M	84.2M	88.4M
Net Invested Capital	(8.1M)	7.5M	44.5M	28.3M	(7.8M)	(7.4M)
Net Working Capital	(1.3M)	7.5M	44.5M	28.3M	5.9M	5.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Annovis Historical Balance Sheet

Annovis Bio Inventory

(637.53 Million)

About Annovis Balance Sheet Analysis

Annovis Bio Balance Sheet Chart

Total Assets

Total Current Liabilities

Accounts Payable

Annovis Bio balance sheet Correlations

Annovis Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Annovis Bio balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Annovis Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Capital Surpluse	+ 1.0	Other Stockholder Equity
Total Current Assets	+ 0.99	Total Assets
Other Stockholder Equity	+ 0.98	Net Tangible Assets
Capital Surpluse	+ 0.98	Net Tangible Assets
Property Plant Equipment	+ 0.98	Net Receivables

Cash And Short Term Investments	- 1.0	Net Debt
Net Debt	- 1.0	Cash
Net Invested Capital	- 0.98	Net Debt
Net Debt	- 0.96	Total Current Assets
Other Stockholder Equity	- 0.93	Retained Earnings
Net Debt	- 0.92	Total Assets